journal article·2009-05-26

Suppression of Human Bone Morphogenetic Protein Signaling by Carboxylated Single-Walled Carbon Nanotubes

Qingxin Mu, Guoqing Du, Taosheng Chen, Bin Zhang, Bing Yan

ACS Nano· Volume 3· Issue 5
Publisher page

Abstract

Effects of carbon nanotubes (CNTs) on living systems such as cells are crucial for the safe development of biosensors, drug carriers, or tumor imaging agents. We report here that SWCNT-COOH inhibited cell proliferation via a nonapoptotic mechanism, which is different from effects caused by pristine CNTs. On the basis of SWCNT-COOH's perturbations on cells, expression of genes and protein, and protein phosphorylations, we conclude that SWCNT-COOH suppresses Smad-dependent bone morphogenetic protein (BMP) signaling pathway and down-regulates Id proteins. These molecular events cause cell cycle arrest at G(1)/S transition and inhibit cell proliferation. The specific suppression of BMP signaling and Id proteins by SWCNT-COOH demonstrates nonapoptotic effects of functionalized CNTs on human cells. This finding may have potential therapeutic applications to treat human diseases related to Id proteins or BMP signaling such as breast cancer and bone diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Metabolism and Diseases · TGF-β signaling in diseases · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

St. Jude Children’s Research Hospital, Memphis, Tennessee 38105

Shandong University, Jinan, China

References (23)

Show source-provided references
1. Ding L. H. · Nano Lett. · 2005 · 5 · 244810.1021/nl051748o ↗
2. Manna S. K. · Nano Lett. · 2005 · 5 · 167610.1021/nl0507966 ↗
3. Zhang T. T. · Nano Lett. · 2006 · 6 · 80010.1021/nl0603350 ↗
4. Zhu L. · Nano Lett. · 2007 · 7 · 359210.1021/nl071303v ↗
5. Chou C. C. · Nano Lett. · 2008 · 8 · 43710.1021/nl0723634 ↗
6. Zhou H. · Nano Lett. · 2008 · 8 · 85910.1021/nl0730155 ↗
7. Mu Q. · J. Phys. Chem. C · 2009 · 113 · 539010.1021/jp809493t ↗
8. Liu Z. · Cancer Res. · 2008 · 68 · 665210.1158/0008-5472.CAN-08-1468 ↗
9. Chakravarty P. · Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 869710.1073/pnas.0803557105 ↗
10. Kam N. W. S. · Angew. Chem., Int. Ed. · 2006 · 45 · 57710.1002/anie.200503389 ↗
11. Huang X. J. · J. Phys. Chem. B · 2006 · 110 · 2185010.1021/jp063749q ↗
12. White M. A. · Annu. Rev. Pharmacol. Toxicol. · 2005 · 45 · 58710.1146/annurev.pharmtox.45.120403.095807 ↗
13. Massague J. · Cell · 2000 · 103 · 29510.1016/S0092-8674(00)00121-5 ↗
14. Cherukuri P. · Proc. Natl. Acad. Sci. U.S.A. · 2006 · 103 · 1888210.1073/pnas.0609265103 ↗
15. Singh R. · Proc. Natl. Acad. Sci. U.S.A. · 2006 · 103 · 335710.1073/pnas.0509009103 ↗
16. Solly K. · Assay Drug Dev. Technol. · 2004 · 2 · 36310.1089/adt.2004.2.363 ↗
17. Norton J. D. · Trends Cell Biol. · 1998 · 8 · 58
18. Hara E. · Dev. Genet. · 1996 · 18 · 16110.1002/(SICI)1520-6408(1996)18:2<161::AID-DVG9>3.0.CO;2-7 ↗
19. Hollnagel A. · J. Biol. Chem. · 1999 · 274 · 1983810.1074/jbc.274.28.19838 ↗
20. Korchynskyi O. · J. Biol. Chem. · 2002 · 277 · 488310.1074/jbc.M111023200 ↗
21. Kang Y. B. · Mol. Cell · 2003 · 11 · 91510.1016/S1097-2765(03)00109-6 ↗
22. Fong S. · Proc. Natl. Acad. Sci. U.S.A. · 2003 · 100 · 1354310.1073/pnas.2230238100 ↗
23. Sulzbacher I. · J. Clin. Pathol. · 2002 · 55 · 38110.1136/jcp.55.5.381 ↗